Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Clinical trial

NCT07768618

1 development in the corpus

NCT07768618

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 17, 2026 · PHASE 2 TRIAL

Electrophysiologic Mechanisms of Ketamine Antidepressant Response

ClinicalTrials.gov

Phase 2 mechanistic study in a highly selected population (epilepsy patients with intracranial electrodes) examining electrophysiologic biomarkers of ketamine response; no results yet reported in this registry record.

PreliminaryNCT07768618 Depressive Symptoms Ketamine

Reported

Planned enrollment37

PhasePhase 2

Ketamine dose0.5 mg/kg over 40 minutes

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support